Publications
CIBMTR Publication List
Since 1972, using CIBMTR data and statistical resources has resulted in more than 1,800 publications.
CIBMTR also makes its publication analysis datasets freely available to the public for secondary analysis while safeguarding participants' privacy and protecting confidential and proprietary data.
Browse Publications
2025 | Blood Advances
CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study.
Authors:
Artz, AS, Logan, BR, Saber, W, Geller, N, Bellach, A, Kou, J, Wood, WA, McCarty, JM, Knight, TG, Runaas, L, Johnston, L, Walston, J, Nakamura, R, Mishra, A, Uberti, J, Dahi, PB, McCurdy, SR, Saultz, JN, Morris, L, Ismus, P, Hogan, WJ, Nadiminti, K, Bhatt, VR, Olin, R, Maakaron, J, Sobecks, R, Wall, S, Mattila, D, Protz, B, Devine, SM, Horowitz, MM, Sorror, ML
2025 | Transplantation and Cellular Therapy
Access to allogeneic cell transplantation based on donor search prognosis: BMT CTN 1702 trial.
Authors:
Dehn, JG, Logan, BR, Lee, SJ, Shaw, BE, Devine, SM, Ciurea, SO, Horowitz, MM, He, N, Pusic, I, Srour, SA, Arai, S, Juckett, M, Uberti, J, Hill, L, Vasu, S, Hogan, WJ, Hayes-Lattin, B, Westervelt, P, Bashey, A, Farhadfar, N, Grunwald, MR, Leifer, E, Symons, H, Saad, A, Vogel, J, Erickson, C, Buck, K, Pidala, J
2025 | Haematologica
CD19 directed CAR T therapy for intravascular large B-cell lymphoma.
Authors:
Patel J, Gopal A, Cherniawsky H, Ram R, Kamble R, Hamadani M
2025 | Blood Advances
Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry.
Authors:
John S, Curran KJ, Hall EM, Keating AK, Baumeister SHC, Nikiforow S, Driscoll T, Moskop A, McNerney KO, Phillips CL, Pulsipher MA, Hsieh EM, Rouce RH, Pasquini MC, Tiwari R, Willert J, Ramos R, Krueger J, Guest E, Grupp SA
2025 | Transplantation and Cellular Therapy
CRS or ICANS are rare beyond 2 weeks after lisocabtagene maraleucel infusion: Data from clinical trials and the real-world setting.
Authors:
Hunter BD, Lunning MA, Shadman M, Ahmed S, Abramson JS, Perales MA, Ahmed N, Mirza AS, Isufi I, Frigault MJ, Crombie JL, Miklos DB, Vasconcelos A, Crotta A, Bernasconi D, Roy D, Bleickardt E, Pasquini MC, Kamdar M
2025 | Leukemia
Defining remission following hematopoietic cell transplant for myelofibrosis: an international expert panel consensus.
Authors:
Salit RB, Hexner EO, Gagelmann N, Kröger N, McLornan DP, Jain T, Gupta V, Hobbs GS, Tamari R, Robin M, Scott B, Saber W
2025 | Transplantation and Cellular Therapy
Acute toxicities of bone marrow donation in unrelated donors with sickle cell trait: A CIBMTR analysis.
Authors:
Farhadfar N, Bo-Subait S, Schmidt G, Logan B, Aljurf M, Badawy S, Beintinjaneh A, Gowda L, Kasow KA, Seftel M, Sharma A, Rangarajan HG, Herr M, Battiwalla M, Shaw B, Stefanski HE
2025 | Blood Advances
Matched unrelated vs haploidentical donor hematopoietic cell transplantation using post-transplant cyclophosphamide.
Authors:
Modi D, Aljawai YM, DeFor TE, Bupp C, Al Malki MM, Bolaños-Meade J, Gooptu M, Jimenez Jimenez AM, Liu H, Mensah F, Mielcarek M, Shaffer BC, Shaw BE, Spellman SR, Stefanski HE, Auletta JJ, Devine SM, Khimani F, Abboud R
2025 | Transplantation and Cellular Therapy
Search summary score: A global measure to predict matched unrelated stem cell donor availability.
Authors:
Fingerson S, Wadsworth K, Bolon YT, Maiers M
2025 | American Journal of Hematology
Germline pathogenic variants in MUTYH are associated with inferior survival after hematopoietic cell transplantation in patients with hematologic malignancies or disorders.
Authors:
Rafati M, Wang Y, Koppayi AL, Savage SA, Godley LA, Williams KM, Porter C, Jones K, Hicks B, Spellman SR, He M, Atshan R, Iwuagwu C, Bolon YT, Arrieta-Bolaños E, Saultz JN, Benjamin CL, Lee SJ, Saber W, Gadalla SM
2025 | JCO Oncology Practice
Impact of publicly reported outcomes on patient selection for hematopoietic cell transplantation.
Authors:
Strouse C, Juckett M, Logan BR, Estrada-Merly N, Peterson A, Preussler JM, Truong TH, Troy JD, Khera N, Wood WA, Rangarajan HG, Akard LP, Bhatt NS, Sharma A, Rizzo JD, Saber W
2025 | Transplantation and Cellular Therapy
Umbilical cord blood transplantation provides an alternative for patients with chronic granulomatous disease lacking HLA-matched donors: A PIDTC report.
Authors:
Arnold DE, Leiding JW, Logan B, Marsh RA, Griffith LM, Grunebaum E, Murguía-Favela L, Mallhi K, Chellapandian D, Deal CL, Lim SS, Prasad V, Heimall J, Chandrakasan S, Chen K, Yu LC, Seroogy CM, Gillio A, Bednarski JJ, Kapoor N, Moore TB, Cuveliar GDE, Touzot F, Rayes A, Ebens CL, Schaefer E, Bauchat A, Chopek A, Burroughs L, Cowan MJ, Dvorak CC, Haddad E, Kohn DB, Notarangelo LD, Pai SY, Puck JM, Pulsipher MA, Torgerson T, Malech HL, Kang EM, Parikh S
2025 | Transplantation and Cellular Therapy
Post-Transplant Cyclophosphamide improves survival in HLA-DPB1 mismatched unrelated donor allogeneic transplantation.
Authors:
McCurdy SR, Solomon SR, Shaffer BC, He M, Bolon YT, Blouin AG, Keyzner A, Socola FA, Ibrahim U, Zou J, Safah H, Saba N, Gadalla S, Perales MA, Paczesny S, Marsh SGE, Petersdorf EW, Wang T, Lee SJ, Fuchs EJ
2025 | Journal of Clinical Oncology
Looking for the best allogeneic donor and the BMT CTN 1702 study: Noli Tempus Perdere.
Authors:
Rambaldi, A
2025 | Transplantation and Cellular Therapy
Corrigendum to: Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy - A report from the CIBMTR, Transplantation and Cellular Therapy, 31:8, August 2025, 505-532; Article Number: JTCT-S-25-00377
Authors:
Spellman SR, Xu K, Oloyede T, Ahn KW, Akhtar OS, Bolon YT, Broglie L, Bloomquist J, Bupp C, Chen M, Devine SM, Jurdi NE, Hamadani M, Hengen M, Huppler AH, Jaglowski S, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Pérez WS, Phelan R, Rizzo D, Saber W, Stefanski HE, Steinert P, Tuschl E, Visotcky A, Vogel R, Auletta JJ, Shaw BE, Allbee-Johnson M
2025 | Transplantation and Cellular Therapy
Performance of treatment response assessment at day 7 by baseline acute graft-versus-host disease severity.
Authors:
Louloudis, IE, Chen, YB, Spyrou, N, Alousi, A, Katsivelos, N, Ayuk, F, Weber, D, Hogan, WJ, Etra, AM, Qayed, M, Aguayo-Hiraldo, P, Akahoshi, Y, Malki, MMA, Bolanos-Meade, J, Chanswangphuwana, C, Diniz, M, Eder, M, Hexner, E, Kitko, CL, Kraus, S, Merli, P, Olson, T, MacMillan, ML, Pidala, J, Reshef, R, Schechter, T, Wolfl, M, Baez, J, Eng, G, Gleich, S, Young, R, Nakamura, R, Ferrara, JLM, Levine, JE
2025 | Blood Advances
Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation.
Authors:
Bhasin-Chhabra, B, Wang, T, Levine, JE, Shenoy, S, Perales, MA, Bashey, A, Raff, H, Saber, W
2025 | British Journal of Haematology
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in new era: A CIBMTR study.
Authors:
Ustun C, Zhang MJ, Peterson A, Baek A, Agha M, Alkhateeb H, Chhabra S, Coltoff A, de Lima M, Gandhi A, Ho V, Kassim A, Lin A, Gowda L, Borthakur G, DeAngelo DJ, McGuirk J, Mensah F, Nadiminti KV, Nishihori T, Pantin J, Trunk A, Gotlib J, Uberti J, Marcucci G, Akin C, Hamadani M, Pullarkat V, Valent P, Grunwald M, Juckett M, Oran B, Saber W, Burns LJ
2025 | Journal of Clinical Oncology
Primary results from Blood and Marrow Transplant Clinical Trials Network 1702: Clinical transplant-related long-term outcomes of alternative donor allogeneic transplantation.
Authors:
Lee, SJ, Logan, BR, Horowitz, MM, Dehn, JG, Pidala, J, Grunwald, MR, Westervelt, P, Farhadfar, N, Hogan, WJ, Bashey, A, Hayes-Lattin, B, Hill, L, Brunstein, C, Arai, S, Srour, SA, Symons, H, Uberti, J, Vasu, S, Pusic, I, Juckett, MB, Leifer, E, He, N, Devine, S, Shaw, B, Ciurea, SO
2025 | Transplantation and Cellular Therapy
Proceedings from the second Reimagining Caregiver Workshop: Addressing caregiver requirements for hematopoietic cell transplant.
Authors:
Preussler JM, DeSalvo AM, Tweeten B, Klaphake J, Cody MR, McGhee PM, Agrawal AK, Archer A, Berman BA, Carollo D, DeMairo K, Montoya Y, Mortel M, Phillips R, Zia M, Schoeppner K, Auletta JJ